원격 환자 모니터링 시스템 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the remote patient monitoring systems market size is expected to increase from USD 85.46 billion in 2025 to USD 102.44 billion in 2026 and reach USD 253.94 billion by 2031, growing at a CAGR of 19.91% over 2026-2031.

This report is Segmented by Device Type (Vital-Sign Monitors, Specialized Disease-Specific Monitors, and More), Application (Cardiovascular Diseases, Diabetes Management, and More), End-User (Hospitals & Clinics, Home-Care Settings, Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Remote Patient Monitoring Systems Market Trends and Insights

Chronic-Disease Burden Escalation

Cardiovascular disease and diabetes now claim over 18 million lives per year, costing high-income economies USD 1.2 trillion annually . Remote patient monitoring platforms convert episodic check-ups into continuous oversight, catching deterioration before a critical event. A 2024 Lancet Digital Health study showed a 33% drop in heart-failure admissions and USD 8,200 savings per patient when implantable pulmonary sensors were used. The Centers for Disease Control confirmed in 2025 that 60% of U.S. adults live with at least one chronic condition, up nine points in five years. Payers are therefore tying reimbursement to outcome metrics, rewarding providers that deploy remote surveillance to prevent emergency episodes. As a result, the Remote patient monitoring system market is tightly coupled to chronic-disease prevalence trends.

Geriatric Population and Home-Care Shift

The world already counts 761 million people aged 65+ and will reach 1.6 billion by 2050. Long-term-care facilities operate at 94% occupancy in the United States, leaving scant surge capacity. Medicare's Hospital-at-Home waiver, extended to December 2026, enables acute-level treatment in residences, provided continuous telemetry meets Joint Commission standards. JAMA Network Open documented a 19% decline in 30-day readmissions and 24% episode-cost savings using home-based RPM kits. This demographic and policy convergence accelerates migration of care from wards to living rooms, further lifting the Remote patient monitoring system market.

Data-Privacy and Cybersecurity Concerns

Ransomware events affecting U.S. providers jumped 45% year on year, with 725 incidents logged in 2025 . Change Healthcare's 2024 breach exposed data for 100 million individuals, underscoring systemic vulnerabilities. The EU imposed a EUR 1.2 billion fine on a multinational EHR vendor in 2025 for inadequate encryption. To regain trust, vendors must fund multifactor authentication and zero-trust architectures, adding 18-22% to per-device costs. Regulatory friction slows deployments and dents growth for the Remote patient monitoring system market.

Other drivers and restraints analyzed in the detailed report include:

1. AI-Based Digital Biomarkers Enabling Predictive RPM
2. Private 5G Hospital Campuses Reducing Latency
3. Interoperability and Integration Costs

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Specialized disease-specific monitors held a 40.12% remote patient monitoring system market share in 2025 . Wearable patches are on track for a 20.11% CAGR, driven by 14-day skin-safe adhesives and Bluetooth Low Energy radios that eliminate bulky transmitters. Abbott's Lingo integrates continuous glucose, lactate, and ketone sensing in a 2 mm patch, avoiding finger-stick calibrations. Multi-parameter monitors cover vital signs for post-surgical home recovery, whereas vital-sign bedside units face margin compression as care migrates home. Implantables like Medtronic's LINQ II capture long-term arrhythmia data with a 4.5-year battery, securing high reimbursement for cryptogenic-stroke cases.

Consumer familiarity with fitness trackers lowers adoption hurdles for patches. Patients prefer disposable devices that avoid sterilization overheads. Journal of Clinical Monitoring and Computing found ambulatory patches offer comparable accuracy to bedside monitors at one-third the capital cost. Specialized monitors maintain supremacy in epilepsy or advanced cardiology, yet commoditization looms as patches add multi-modal sensors. Multi-parameter devices serve transitional-care scenarios, strengthened by Medicare's Hospital-at-Home waiver. This product-mix evolution anchors sustained revenue diversification inside the Remote patient monitoring system market.

Complete Report Scope:

• By Device Type
  • Vital-sign Monitors
  • Specialized Disease-specific Monitors
  • Multi-parameter Monitors
  • Wearable Sensor Patches
  • Implantable Sensors
• By Application
  • Cardiovascular Diseases
  • Diabetes Management
  • Respiratory (COPD / Asthma)
  • Oncology Support
  • Sleep & Mental-health Monitoring
  • Weight Management & Fitness
• By End-User
  • Hospitals & Clinics
  • Home-care Settings
  • Ambulatory Surgical centers
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa
    • GCC
    • South Africa
    • Rest of Middle East and Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America captured 41.22% of 2025 revenue, propelled by Medicare's expanded codes and the VA commitment to universal RPM by 2027. Twelve million Medicare beneficiaries were enrolled by December 2025, up from 4.8 million two years earlier. Canada earmarked CAD 200 million (USD 148 million) for rural virtual care, including RPM, while Mexico piloted diabetes and hypertension monitoring across 80,000 patients.

Asia-Pacific is forecast to grow at 21.78% CAGR through 2031. China reimburses RPM for hypertension, diabetes, and COPD under its Healthy China 2030 blueprint. India's Ayushman Bharat Digital Mission connected 200 million citizens to cloud health records by late 2025. Japan allows RPM chronic-care management without clinic visits; South Korea pilots post-stroke surveillance in Seoul and Busan. Australia added telehealth item numbers for RPM in 2024, though reimbursement sits 30% below in-person rates.

Europe held a significant share in 2025. Germany reimburses certified digital health applications, approving over 40 RPM tools by mid-2025. The UK allocated GBP 250 million for remote heart-failure and COPD monitoring. France cleared 12 devices under its connected-medical-device pathway, though integration with the national EHR lags. GCC states such as the UAE launched a 10,000-patient diabetes pilot in 2025, indicating early traction. Infrastructure gaps and limited reimbursement restrain broader MEA and South American adoption, but multi-lateral development loans targeting digital health could unlock latent demand, bolstering the Remote patient monitoring system market over the long term.

1. Abbott Laboratories
2. Aerotel Medical Systems
3. AliveCor
4. AMD Global Telemedicine
5. Baxter
6. Koninklijke Philips
7. Boston Scientific
8. Dexcom
9. GE Healthcare
10. Honeywell Life Sciences
11. Masimo
12. Medtronic
13. Nihon Kohden
14. OMRON
15. Koninklijke Philips
16. Resmed
17. Teladoc Health
18. Tunstall Healthcare
19. Vital Connect
20. VivaLNK

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Chronic-Disease Burden Escalation
  • 4.2.2 Geriatric Population & Home-Care Shift
  • 4.2.3 Favorable Reimbursement Expansion
  • 4.2.4 Post-COVID Telehealth Normalization
  • 4.2.5 AI-Based Digital Biomarkers Enabling Predictive RPM
  • 4.2.6 Private-5G Hospital Campuses Reducing Latency For RPM
• 4.3 Market Restraints
  • 4.3.1 Data-Privacy & Cybersecurity Concerns
  • 4.3.2 Interoperability & Integration Costs
  • 4.3.3 Tariff / Cross-Border Data-Localization Cost Inflation
  • 4.3.4 Device Fatigue & Long-Term Patient Adherence
• 4.4 Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Intensity of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Device Type
  • 5.1.1 Vital-sign Monitors
  • 5.1.2 Specialized Disease-specific Monitors
  • 5.1.3 Multi-parameter Monitors
  • 5.1.4 Wearable Sensor Patches
  • 5.1.5 Implantable Sensors
• 5.2 By Application
  • 5.2.1 Cardiovascular Diseases
  • 5.2.2 Diabetes Management
  • 5.2.3 Respiratory (COPD / Asthma)
  • 5.2.4 Oncology Support
  • 5.2.5 Sleep & Mental-health Monitoring
  • 5.2.6 Weight Management & Fitness
• 5.3 By End-User
  • 5.3.1 Hospitals & Clinics
  • 5.3.2 Home-care Settings
  • 5.3.3 Ambulatory Surgical centers
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 South Korea
    • 5.4.3.5 Australia
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
  • 6.3.1 Abbott Laboratories
  • 6.3.2 Aerotel Medical Systems
  • 6.3.3 AliveCor
  • 6.3.4 AMD Global Telemedicine
  • 6.3.5 Baxter International
  • 6.3.6 Koninklijke Philips N.V.
  • 6.3.7 Boston Scientific
  • 6.3.8 Dexcom
  • 6.3.9 GE Healthcare
  • 6.3.10 Honeywell Life Sciences
  • 6.3.11 Masimo
  • 6.3.12 Medtronic
  • 6.3.13 Nihon Kohden
  • 6.3.14 Omron Corporation
  • 6.3.15 Philips Healthcare
  • 6.3.16 ResMed
  • 6.3.17 Teladoc Health
  • 6.3.18 Tunstall Healthcare
  • 6.3.19 VitalConnect
  • 6.3.20 VivaLNK

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment